Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

T3 augmentation in major depressive disorder: safety considerations.

Rosenthal LJ, Goldner WS, O'Reardon JP.

Am J Psychiatry. 2011 Oct;168(10):1035-40. doi: 10.1176/appi.ajp.2011.10030402. No abstract available.

PMID:
21969047
2.

Triiodothyronine addition to paroxetine in the treatment of major depressive disorder.

Appelhof BC, Brouwer JP, van Dyck R, Fliers E, Hoogendijk WJ, Huyser J, Schene AH, Tijssen JG, Wiersinga WM.

J Clin Endocrinol Metab. 2004 Dec;89(12):6271-6.

PMID:
15579788
3.

Lithium and triiodothyronine augmentation of antidepressants.

Joffe RT, Sokolov ST, Levitt AJ.

Can J Psychiatry. 2006 Oct;51(12):791-3.

PMID:
17168254
4.

T3 augmentation of SSRI resistant depression.

Abraham G, Milev R, Stuart Lawson J.

J Affect Disord. 2006 Apr;91(2-3):211-5. Epub 2006 Feb 17.

PMID:
16483669
5.

Long term augmentation with T3 in refractory major depression.

Kelly TF, Lieberman DZ.

J Affect Disord. 2009 May;115(1-2):230-3. doi: 10.1016/j.jad.2008.09.022. Epub 2008 Dec 23.

PMID:
19108898
6.

Can nonantidepressants help treat depression?

Chilakamarri G, Weismantel D, Weismantel A.

J Fam Pract. 2009 Oct;58(10):550-1. No abstract available.

PMID:
19874735
7.
8.

A pilot effectiveness study: placebo-controlled trial of adjunctive L-triiodothyronine (T3) used to accelerate and potentiate the antidepressant response.

Posternak M, Novak S, Stern R, Hennessey J, Joffe R, Prange A Jr, Zimmerman M.

Int J Neuropsychopharmacol. 2008 Feb;11(1):15-25. Epub 2007 Mar 13.

PMID:
17352847
9.

Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine.

Cooper-Kazaz R, Cohen A, Lerer B.

J Clin Psychopharmacol. 2010 Apr;30(2):211-2. doi: 10.1097/JCP.0b013e3181d273b3. No abstract available.

PMID:
20520303
10.

The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder.

Garlow SJ, Dunlop BW, Ninan PT, Nemeroff CB.

J Psychiatr Res. 2012 Nov;46(11):1406-13. doi: 10.1016/j.jpsychires.2012.08.009. Epub 2012 Sep 7.

11.
13.

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.

Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.

Arch Gen Psychiatry. 2007 Jun;64(6):679-88.

PMID:
17548749
14.

An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.

Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M.

J Clin Psychiatry. 2005 Aug;66(8):1038-42.

PMID:
16086620
15.

Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies.

Papakostas GI, Cooper-Kazaz R, Appelhof BC, Posternak MA, Johnson DP, Klibanski A, Lerer B, Fava M.

Int Clin Psychopharmacol. 2009 Jan;24(1):19-25. doi: 10.1097/YIC.0b013e328314dfaf. Review.

PMID:
19092448
16.

Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder.

Iosifescu DV, Bolo NR, Nierenberg AA, Jensen JE, Fava M, Renshaw PF.

Biol Psychiatry. 2008 Jun 15;63(12):1127-34. doi: 10.1016/j.biopsych.2007.11.020. Epub 2008 Jan 22.

PMID:
18206856
17.

Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression?

Gervasoni N, Aubry JM, Gex-Fabry M, Bertschy G, Bondolfi G.

Pharmacol Res. 2009 Mar;59(3):202-6. doi: 10.1016/j.phrs.2008.11.005. Epub 2008 Nov 27.

PMID:
19073260
18.
19.

Appearance of mania in drug-resistant bipolar depressed patients after treatment with L-triiodothyronine.

Evans DL, Strawn SK, Haggerty JJ Jr, Garbutt JC, Burnett GB, Pedersen CA.

J Clin Psychiatry. 1986 Oct;47(10):521-2.

PMID:
3759918
20.

Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder.

Agid O, Shalev AY, Lerer B.

J Clin Psychiatry. 2001 Mar;62(3):169-73.

PMID:
11305702
Items per page

Supplemental Content

Write to the Help Desk